SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001140361-17-047643
Filing Date
2017-12-28
Accepted
2017-12-28 18:38:57
Documents
1
Period of Report
2017-12-13

Document Format Files

Seq Description Document Type Size
1 form4.html 4/A  
1 form4.xml 4/A 9825
  Complete submission text file 0001140361-17-047643.txt   11334
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2000 MCKINNEY SUITE 2125 DALLAS TX 75201
Business Address 2000 MCKINNEY SUITE 2125 DALLAS TX 75201 214-871-6816
CPMG Inc (Reporting) CIK: 0001372218 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-37785 | Film No.: 171279403